Analysed BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) News Sources
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
09-10-2025
yahoo.com
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
18-06-2026
yahoo.com
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
07-07-2026
yahoo.com
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD
22-07-2026
yahoo.com
What is the current price of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?
The current price of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is $0.094.
BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) since the previous trading day is $0.0065.
BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) since the previous trading day is 7.4286%.
What is the most recent average sentiment score for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?
The most recent average sentiment score for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?
The most recent sentiment for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is .
SEC-8K** Filing Available For BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.